NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
12.08
-0.11 (-0.90%)
At close: Sep 3, 2025, 4:00 PM
11.90
-0.18 (-1.49%)
After-hours: Sep 3, 2025, 7:40 PM EDT

NovoCure Stock Forecast

Stock Price Forecast

The 7 analysts that cover NovoCure stock have a consensus rating of "Buy" and an average price target of $28.79, which forecasts a 138.33% increase in the stock price over the next year. The lowest target is $14.5 and the highest is $38.

Price Target: $28.79 (+138.33%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$14.5$28.79$30$38
Change+20.03%+138.33%+148.34%+214.57%
* Price targets were last updated on Jul 25, 2025.

Analyst Ratings

The average analyst rating for NovoCure stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111122
Buy333322
Hold122233
Sell000000
Strong Sell000000
Total566677

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Hold
Downgrades
$40$15
HoldDowngrades$40$15+20.03%Jul 25, 2025
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$30
Strong BuyInitiates$30+148.34%Jul 8, 2025
Piper Sandler
Piper Sandler
Buy
Reiterates
$34
BuyReiterates$34+181.46%Jun 27, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$42$34
BuyMaintains$42$34+181.46%Apr 23, 2025
Wedbush
Wedbush
Hold
Maintains
$29$27
HoldMaintains$29$27+123.51%Apr 16, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
645.64M
from 605.22M
Increased by 6.68%
Revenue Next Year
690.88M
from 645.64M
Increased by 7.01%
EPS This Year
-1.61
from -1.56
EPS Next Year
-1.74
from -1.61
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
494.37M535.03M537.84M509.34M605.22M645.64M690.88M
Revenue Growth
40.72%8.23%0.53%-5.30%18.83%6.68%7.01%
EPS
0.18-0.56-0.88-1.95-1.56-1.61-1.74
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High685.7M749.3M
Avg645.6M690.9M
Low605.2M637.9M

Revenue Growth

Revenue Growth20252026202720282029
High
13.3%
16.1%
Avg
6.7%
7.0%
Low
-0.0%
-1.2%

EPS Forecast

EPS20252026202720282029
High-1.52-1.62
Avg-1.61-1.74
Low-1.63-1.80

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.